{"transactions":[{"id":1723476,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-04T17:55:37.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years."}],"balance_after":153000,"derivative":{"exercise_price":7.66,"expiration_date":"2033-11-30","underlying":"Common Shares","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0000929638-23-003341","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553037/000092963823003341/form4.xml","form_type":"4"}},{"id":2007767,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-17T18:21:08.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 110,000 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":110000,"derivative":{"exercise_price":9.3,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001104659-23-023388","document":"tm237300-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465923023388/tm237300-3_4seq1.xml","form_type":"4"}},{"id":2411746,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T16:40:10.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":53064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 53,064 shares of the Issuer's common stock, one quarter of which will vest on January 7, 2023, with the remaining three quarters vesting in equal monthly installments through January 7, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":53064,"derivative":{"exercise_price":12.01,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":53064},"source":{"system":"sec-edgar","filing":"0000899243-22-004836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322004836/doc4.xml","form_type":"4"}},{"id":2755630,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2021-04-06T21:54:59.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":426,"price":9.8029,"value":4176.0354,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":121662,"source":{"system":"sec-edgar","filing":"0001209191-21-025726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121025726/doc4.xml","form_type":"4"}},{"id":2808542,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2021-03-04T21:40:12.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":422,"price":10.15,"value":4283.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":122088,"source":{"system":"sec-edgar","filing":"0001209191-21-017836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121017836/doc4.xml","form_type":"4"}},{"id":2845904,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2021-02-19T23:22:19.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":74341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to (i) one-third (1/3) of the Shares (as defined in the Plan) underlying the Option on the first anniversary of January 1, 2021 (the \"Vesting Commencement Date\")and (ii) one-sixth (1/6th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023, and January 1, 2024."}],"balance_after":74341,"derivative":{"exercise_price":12.02,"expiration_date":"2031-02-16","underlying":"COMMON STOCK","underlying_shares":74341},"source":{"system":"sec-edgar","filing":"0001209191-21-012523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121012523/doc4.xml","form_type":"4"}},{"id":2845903,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2021-02-19T23:22:19.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":52846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to (i) one-third (1/3) of the Restricted Stock Units on the first anniversary of of the commencement date of January 1, 2021 (the \"Vesting Commencement Date\") and (ii) one-sixth (1/6th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024."}],"balance_after":122510,"source":{"system":"sec-edgar","filing":"0001209191-21-012523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121012523/doc4.xml","form_type":"4"}},{"id":2881393,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2021-02-04T00:39:02.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":415,"price":12.2312,"value":5075.948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.2306 to $12.2480, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":69664,"source":{"system":"sec-edgar","filing":"0001209191-21-007534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121007534/doc4.xml","form_type":"4"}},{"id":2915226,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2021-01-06T23:36:20.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":6548,"price":10.2346,"value":67016.1608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70079,"source":{"system":"sec-edgar","filing":"0001209191-21-002327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121002327/doc4.xml","form_type":"4"}},{"id":2956463,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-12-04T21:34:55.000Z","date":"2020-12-02","kind":"sale","acquired":false,"shares":92,"price":11.65,"value":1071.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":76627,"source":{"system":"sec-edgar","filing":"0001209191-20-061811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120061811/doc4.xml","form_type":"4"}},{"id":2994540,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-11-04T00:28:48.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":97,"price":7.81,"value":757.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":76719,"source":{"system":"sec-edgar","filing":"0001209191-20-056784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120056784/doc4.xml","form_type":"4"}},{"id":3012966,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-10-05T21:25:35.000Z","date":"2020-10-02","kind":"sale","acquired":false,"shares":91,"price":10.144,"value":923.104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":76816,"source":{"system":"sec-edgar","filing":"0001209191-20-053766","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120053766/doc4.xml","form_type":"4"}},{"id":3038987,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-09-03T21:27:34.000Z","date":"2020-09-02","kind":"sale","acquired":false,"shares":90,"price":9.77,"value":879.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":76907,"source":{"system":"sec-edgar","filing":"0001209191-20-049481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120049481/doc4.xml","form_type":"4"}},{"id":3067231,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-08-05T20:35:14.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":86,"price":10.8,"value":928.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":76997,"source":{"system":"sec-edgar","filing":"0001209191-20-045120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120045120/doc4.xml","form_type":"4"}},{"id":3088617,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-07-07T00:02:23.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":660,"price":10.6673,"value":7040.418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.5701 to $10.6676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":77083,"source":{"system":"sec-edgar","filing":"0001209191-20-041329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120041329/doc4.xml","form_type":"4"}},{"id":3123733,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-06-03T21:26:59.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":89,"price":10.66,"value":948.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":77743,"source":{"system":"sec-edgar","filing":"0001209191-20-034136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120034136/doc4.xml","form_type":"4"}},{"id":3159320,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-05-06T20:55:20.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":89,"price":9.6201,"value":856.1889,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":77832,"source":{"system":"sec-edgar","filing":"0001209191-20-027503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120027503/doc4.xml","form_type":"4"}},{"id":3182917,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-04-03T20:42:11.000Z","date":"2020-04-02","kind":"sale","acquired":false,"shares":91,"price":7.3701,"value":670.6791,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":77921,"source":{"system":"sec-edgar","filing":"0001209191-20-023194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120023194/doc4.xml","form_type":"4"}},{"id":3231753,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-03-03T21:41:28.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":96,"price":10.0224,"value":962.1504,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":78012,"source":{"system":"sec-edgar","filing":"0001209191-20-015251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120015251/doc4.xml","form_type":"4"}},{"id":3273754,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2020-02-14T00:59:17.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":54842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date (\"Option Vesting Commencement Date\") of the option is January 1, 2020. The option vests (i) with respect to one-third (1/3rd) of the shares underlying the option on the first anniversary of the Option Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option on each monthly anniversary of the Option Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":54842,"derivative":{"exercise_price":12.34,"expiration_date":"2030-02-10","underlying":"COMMON STOCK","underlying_shares":54842},"source":{"system":"sec-edgar","filing":"0001209191-20-009445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120009445/doc4.xml","form_type":"4"}},{"id":3273753,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-02-14T00:59:17.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":43274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the vesting commencement date of January 1, 2020 (\"Vesting Commencement Date\") and (ii) with respect to 1/36th of the shares subject thereto on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":78108,"source":{"system":"sec-edgar","filing":"0001209191-20-009445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120009445/doc4.xml","form_type":"4"}},{"id":3291257,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-02-04T22:41:28.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":105,"price":8.015,"value":841.575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":34834,"source":{"system":"sec-edgar","filing":"0001209191-20-006488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120006488/doc4.xml","form_type":"4"}},{"id":3322514,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-01-03T21:31:59.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":1514,"price":8.4,"value":12717.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":34939,"source":{"system":"sec-edgar","filing":"0001209191-20-001000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120001000/doc4.xml","form_type":"4"}},{"id":3322513,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2020-01-03T21:31:59.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":2,"price":8.36,"value":16.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":36453,"source":{"system":"sec-edgar","filing":"0001209191-20-001000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120001000/doc4.xml","form_type":"4"}},{"id":3353955,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-12-04T01:53:11.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":83,"price":10.3401,"value":858.2283,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":36455,"source":{"system":"sec-edgar","filing":"0001209191-19-058925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119058925/doc4.xml","form_type":"4"}},{"id":3380044,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-11-05T21:34:29.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":88,"price":7.3801,"value":649.4488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":36538,"source":{"system":"sec-edgar","filing":"0001209191-19-055216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119055216/doc4.xml","form_type":"4"}},{"id":3398359,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-10-03T20:35:56.000Z","date":"2019-10-02","kind":"sale","acquired":false,"shares":91,"price":10.05,"value":914.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":36626,"source":{"system":"sec-edgar","filing":"0001209191-19-052231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119052231/doc4.xml","form_type":"4"}},{"id":3421678,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-09-05T20:51:05.000Z","date":"2019-09-04","kind":"sale","acquired":false,"shares":95,"price":10.11,"value":960.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":36717,"source":{"system":"sec-edgar","filing":"0001209191-19-048558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119048558/doc4.xml","form_type":"4"}},{"id":3446857,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-08-05T22:20:44.000Z","date":"2019-08-02","kind":"sale","acquired":false,"shares":94,"price":9,"value":846.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":36812,"source":{"system":"sec-edgar","filing":"0001209191-19-044681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119044681/doc4.xml","form_type":"4"}},{"id":3456622,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-07-24T20:36:37.000Z","date":"2019-07-22","kind":"sale","acquired":false,"shares":1841,"price":10.0971,"value":18588.7611,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.06 to $10.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":36906,"source":{"system":"sec-edgar","filing":"0001209191-19-043049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119043049/doc4.xml","form_type":"4"}},{"id":3467798,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-07-03T22:05:28.000Z","date":"2019-07-02","kind":"sale","acquired":false,"shares":89,"price":12.78,"value":1137.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":38747,"source":{"system":"sec-edgar","filing":"0001209191-19-041266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119041266/doc4.xml","form_type":"4"}},{"id":3500337,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-06-06T00:04:54.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":88,"price":15.07,"value":1326.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":38836,"source":{"system":"sec-edgar","filing":"0001209191-19-034961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119034961/doc4.xml","form_type":"4"}},{"id":3537913,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-05-06T20:39:05.000Z","date":"2019-05-02","kind":"sale","acquired":false,"shares":85,"price":32.3801,"value":2752.3085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":38924,"source":{"system":"sec-edgar","filing":"0001209191-19-027727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119027727/doc4.xml","form_type":"4"}},{"id":3564426,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-04-03T21:00:48.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":88,"price":35.7801,"value":3148.6488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":39009,"source":{"system":"sec-edgar","filing":"0001209191-19-023265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119023265/doc4.xml","form_type":"4"}},{"id":3580964,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-03-22T20:53:50.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":88,"price":38.66,"value":3402.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":39097,"source":{"system":"sec-edgar","filing":"0001209191-19-021012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119021012/doc4.xml","form_type":"4"}},{"id":3667924,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2019-02-08T22:34:41.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":15400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date (\"Option Vesting Commencement Date\") of the option is January 1, 2019. The option vests (i) with respect to one-third (1/3rd) of the shares underlying the option on the first anniversary of the Option Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option on each monthly anniversary of the Option Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":15400,"derivative":{"exercise_price":27.76,"expiration_date":"2029-02-05","underlying":"COMMON STOCK","underlying_shares":15400},"source":{"system":"sec-edgar","filing":"0001209191-19-008683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119008683/doc4.xml","form_type":"4"}},{"id":3667923,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-02-08T22:34:41.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the vesting commencement date of January 1, 2019 (\"RSU Vesting Commencement Date\") and (ii) with respect to 1/6th of the shares subject thereto on each six-month anniversary of the RSU Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":39185,"source":{"system":"sec-edgar","filing":"0001209191-19-008683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119008683/doc4.xml","form_type":"4"}},{"id":3672210,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-02-06T21:34:27.000Z","date":"2019-02-04","kind":"sale","acquired":false,"shares":89,"price":27.77,"value":2471.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":29285,"source":{"system":"sec-edgar","filing":"0001209191-19-007743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119007743/doc4.xml","form_type":"4"}},{"id":3687968,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-01-24T21:47:44.000Z","date":"2019-01-22","kind":"sale","acquired":false,"shares":1959,"price":24.72,"value":48426.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":29374,"source":{"system":"sec-edgar","filing":"0001209191-19-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119005183/doc4.xml","form_type":"4"}},{"id":3703724,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2019-01-04T22:08:09.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":1210,"price":20.67,"value":25010.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":31333,"source":{"system":"sec-edgar","filing":"0001209191-19-002078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119002078/doc4.xml","form_type":"4"}},{"id":3862161,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2018-07-24T21:03:28.000Z","date":"2018-07-20","kind":"sale","acquired":false,"shares":1836,"price":51.9506,"value":95381.3016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.95 to $52.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":32543,"source":{"system":"sec-edgar","filing":"0001209191-18-043760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118043760/doc4.xml","form_type":"4"}},{"id":4008027,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2018-03-07T21:34:07.000Z","date":"2018-02-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the vesting commencement date of January 1, 2018 (\"Vesting Commencement Date\") and (ii) with respect to 1/36th of the shares subject thereto on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"This amended Form 4 is filed solely for the purpose of correcting an administrative error in column 4 reporting securities as disposed of, instead of acquired, as reported on the Form 4 filed February 13, 2018."}],"balance_after":34379,"source":{"system":"sec-edgar","filing":"0001209191-18-017738","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118017738/doc4a.xml","form_type":"4/A","original_submission_date":"2018-02-13"}},{"id":4062599,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2018-02-13T22:57:38.000Z","date":"2018-02-11","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is January 1, 2018. The option vests (i) with respect to one-third (1/3rd) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":14000,"derivative":{"exercise_price":60.85,"expiration_date":"2028-02-10","underlying":"COMMON STOCK","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-18-009705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118009705/doc4.xml","form_type":"4"}},{"id":4062598,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"COMMON STOCK","published_at":"2018-02-13T22:57:38.000Z","date":"2018-02-11","kind":"grant","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the vesting commencement date of January 1, 2018 (\"Vesting Commencement Date\") and (ii) with respect to 1/36th of the shares subject thereto on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":34379,"source":{"system":"sec-edgar","filing":"0001209191-18-009705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118009705/doc4.xml","form_type":"4"}},{"id":4090987,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2018-01-24T21:33:10.000Z","date":"2018-01-22","kind":"sale","acquired":false,"shares":1860,"price":92.75,"value":172515.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":25379,"source":{"system":"sec-edgar","filing":"0001209191-18-005127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118005127/doc4.xml","form_type":"4"}},{"id":4197589,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2017-10-02T20:24:38.000Z","date":"2017-09-29","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and is exercisable."}],"balance_after":67000,"derivative":{"exercise_price":11.3,"expiration_date":"2022-06-26","underlying":"COMMON STOCK","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-054619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117054619/doc4.xml","form_type":"4"}},{"id":4197588,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-10-02T20:24:38.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":15000,"price":120,"value":1800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27239,"source":{"system":"sec-edgar","filing":"0001209191-17-054619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117054619/doc4.xml","form_type":"4"}},{"id":4197587,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-10-02T20:24:38.000Z","date":"2017-09-29","kind":"exercise","acquired":true,"shares":15000,"price":11.3,"value":169500.0,"ownership":{"direct":true},"balance_after":42239,"source":{"system":"sec-edgar","filing":"0001209191-17-054619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117054619/doc4.xml","form_type":"4"}},{"id":4213524,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2017-09-08T20:11:19.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and is exercisable."}],"balance_after":82000,"derivative":{"exercise_price":11.3,"expiration_date":"2022-06-26","underlying":"COMMON STOCK","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-17-052039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117052039/doc4.xml","form_type":"4"}},{"id":4213523,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2017-09-08T20:11:19.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and is exercisable."}],"balance_after":96000,"derivative":{"exercise_price":11.3,"expiration_date":"2022-06-26","underlying":"COMMON STOCK","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-17-052039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117052039/doc4.xml","form_type":"4"}},{"id":4213522,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-09-08T20:11:19.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":14000,"price":100.1,"value":1401400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27239,"source":{"system":"sec-edgar","filing":"0001209191-17-052039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117052039/doc4.xml","form_type":"4"}},{"id":4213521,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-09-08T20:11:19.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":14000,"price":11.3,"value":158200.0,"ownership":{"direct":true},"balance_after":41239,"source":{"system":"sec-edgar","filing":"0001209191-17-052039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117052039/doc4.xml","form_type":"4"}},{"id":4213520,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-09-08T20:11:19.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":1000,"price":100,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27239,"source":{"system":"sec-edgar","filing":"0001209191-17-052039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117052039/doc4.xml","form_type":"4"}},{"id":4213519,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-09-08T20:11:19.000Z","date":"2017-09-06","kind":"exercise","acquired":true,"shares":1000,"price":11.3,"value":11300.0,"ownership":{"direct":true},"balance_after":28239,"source":{"system":"sec-edgar","filing":"0001209191-17-052039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117052039/doc4.xml","form_type":"4"}},{"id":4252578,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-07-24T21:10:58.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":7,"price":95.2001,"value":666.4007,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":27239,"source":{"system":"sec-edgar","filing":"0001209191-17-046089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117046089/doc4.xml","form_type":"4"}},{"id":4252577,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-07-24T21:10:58.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":1991,"price":94.4806,"value":188110.8746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.1589 to $94.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":27246,"source":{"system":"sec-edgar","filing":"0001209191-17-046089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117046089/doc4.xml","form_type":"4"}},{"id":4257084,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2017-07-14T22:01:24.000Z","date":"2017-07-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and is exercisable."}],"balance_after":97000,"derivative":{"exercise_price":11.3,"expiration_date":"2022-06-26","underlying":"COMMON STOCK","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-045240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117045240/doc4.xml","form_type":"4"}},{"id":4257083,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-07-14T22:01:24.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":5000,"price":87.1,"value":435500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":29237,"source":{"system":"sec-edgar","filing":"0001209191-17-045240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117045240/doc4.xml","form_type":"4"}},{"id":4257082,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-07-14T22:01:24.000Z","date":"2017-07-03","kind":"exercise","acquired":true,"shares":5000,"price":11.3,"value":56500.0,"ownership":{"direct":true},"balance_after":34237,"source":{"system":"sec-edgar","filing":"0001209191-17-045240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117045240/doc4.xml","form_type":"4"}},{"id":4435876,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2017-02-21T21:45:09.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is February 16, 2017. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":31500,"derivative":{"exercise_price":37.35,"expiration_date":"2027-02-15","underlying":"COMMON STOCK","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-17-012749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117012749/doc4.xml","form_type":"4"}},{"id":4482913,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2017-01-24T22:51:21.000Z","date":"2017-01-20","kind":"sale","acquired":false,"shares":2293,"price":33.2351,"value":76208.0843,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":29237,"source":{"system":"sec-edgar","filing":"0001209191-17-005347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919117005347/doc4.xml","form_type":"4"}},{"id":4579573,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":107771,"kind":"person","name":"BRYCE RICHARD PAUL","position":1,"cik":"0001553037","reported_name":"BRYCE RICHARD PAUL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR VP, CLINICAL RESEARCH & DEV"}}],"security":"COMMON STOCK","published_at":"2016-10-15T01:12:00.000Z","date":"2016-10-14","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in six substantially equal installments on each six-month anniversary of the Vesting Commencement Date of July 19, 2016, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":31530,"source":{"system":"sec-edgar","filing":"0001209191-16-145978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919116145978/doc4.xml","form_type":"4"}}]}